Comprehensive Stool Analysis: The Wrong Enemy on the Report

A man of thirty-nine brings in a glossy printout with two lines highlighted in yellow. He has spent two years and real money on those lines: three antifungal protocols, two rounds of herbal antimicrobials, a course of metronidazole from an online consultation, and a diet with fourteen forbidden foods. He still bloats and he is still tired. His comprehensive stool analysis was not wrong. It was answering a question that cannot fix him.

The chapter video, The Wrong Enemy on Your Stool Report, carries the core argument from The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Here is the measurement half: what a panel can establish, what a diversity number predicts, and what has actually been shown to rebuild a terrain.

A test can be accurate and still buy you nothing

Hunt for common organisms in people unlikely to be sick and detections rise while the number of people helped stays flat. A children’s hospital network swapped conventional stool testing for a multiplex PCR panel: positive results climbed to 40% from 11% and came back in 4 hours rather than 31. Children treated for a bacterial or parasitic pathogen went home two days sooner, but they were 3% of those tested, and across the whole population there was no difference in length of stay, extra testing or charges. The authors’ term for it was low-value care, and this was a before-and-after design rather than a study of accuracy.

Sixty-nine specialists reached the same place in a consensus statement, writing that consumer microbiome tests are sold “without any consensus on their regulation or any proven value in clinical practice.” Expert opinion is not data. It is also the only professional standard that exists here. Repeatability is its own problem:why one stool sample can return several different answers.

The fungal result that will not repeat itself

Before acting on a fungal line, ask whether the same person would produce it twice. Fungi in stool have been traced back to the mouth and the plate rather than to a colony living in the bowel: between 0.01% and 0.1% of metagenomic reads from adult stool map to fungal species, which is a rounding error against a load counted in trillions, and fungi would not grow on a medium that supports nearly every bacterial species sequencing finds there. Two details make it domestic rather than academic. Levels of C. albicans in stool dropped dramatically with more frequent tooth brushing. And in one volunteer, an unintended piece of bread pushed baker’s yeast back to 16% of fungal reads inside a day. Brushing your teeth moves your result. So does breakfast on collection morning.

Four controlled-diet volunteers is a small study, and those authors drew the line themselves: fungi do cause serious infections in the immunocompromised.

What the diversity line on a comprehensive stool analysis predicts

The number everyone reaches for does not do what they think. In a Finnish mortality cohort, composition alone predicted death with a C-statistic of 0.634, while ordinary clinical risk factors reached 0.798. Adding the microbiome to those risk factors moved the number to 0.796, which is nothing, at a P of 0.11. The component carrying the whole signal explained 1.4% of the variation between people. Its top quarter ran a 49% greater risk of death than its bottom quarter, which sounds enormous until you notice how little of anyone’s community it describes.

Then the confounder that never appears on a report. In 53 healthy women, stool consistency correlated with every known major microbiome marker and ran negatively against species richness, with faster transit favoring fast-growing species. A low richness score may be reporting how quickly things move through you. Richness also swings on a calendar: across a year of Hadza stool samples, some taxa vanished and returned in a later season, so the wrong month reads as depleted.

So a high count is not a verdict and a low count is not a diagnosis. Diversity is what a gut looks like when the terrain is working, not the lever that makes it work. Same discipline as making every marker in a workup earn its place before anyone treats it.

An old friend, subtyped

The protozoan on his report has subtypes, and they are not interchangeable. Among 2,524 people referred for parasite testing in Italy, microscopy found Blastocystis in 192, or 7.6%. Subtype 3 accounted for 40% of them, and those carriers showed higher bacterial diversity. Read the next line twice: a high percentage of Enterobacteriaceae was found in the subjects who carried no Blastocystis at all. The family that predicts mortality was enriched in the people whose test came back clean.

Microscopy is far less sensitive than PCR, so 7.6% is a floor rather than a prevalence, and all of this is association. A large metabolic cohort points at the likely explanation: those microbe associations were driven especially by the presence and diversity of healthy, plant-based foods. The organism may be riding on the diet, and that cohort ran through a commercial nutrition company with an interest in such advice.

A marker of a good gut is not a treatment target. It is a receipt.

What has been shown to rebuild a community

Food has the better evidence, and the trial testing it is more honest than the marketing around it. Healthy adults were randomized to add either 20 grams of fiber a day or 6 servings a day of fermented foods for 10 weeks. The prespecified primary outcome, a cytokine response score, was not significant in either arm. Among the secondary findings, 19 of 93 inflammatory serum proteins fell in the fermented arm, including IL-6, and none moved with fiber, which instead raised the community’s glycan-degrading capacity while diversity stayed flat. Small arms, no blinding, everything secondary to a null endpoint. The shape is still the practical answer: feeding a community changes what it does before it changes who belongs to it, and neither arm needed a kill.

After antibiotics the instinct is a capsule, and that was tested directly. Probiotics produced a markedly delayed and persistently incomplete return of a person’s own community, while reinfusing that person’s banked stool restored it within days. Colonization resistance also breaks under proton pump inhibitors, antidiabetics and antipsychotics, so a medication list often explains more than a panel does. Same terrain argument that decides why one person heals from a procedure and another does not.

What I told him, and what we measured instead

I stopped treating a species list as a diagnosis, and I said so plainly. Both organisms on his report are common in people who feel well, and a name on a page says nothing about what his gut is doing. So we measured activity instead: breath hydrogen and methane, an inflammatory marker, and a truthful record of a week of food. Then three months of deliberate building, with fermentable plant material arriving most days, because that is what the producers eat.

The next part of the series runs the opposite direction, by subtraction: the small bowel needs stretches of being empty while the colon needs feeding. When killing is genuinely necessary, repopulating afterward is its own protocol. Every study and every number, with what each shows and what it cannot, is gathered in the Deep Dive, along with the questions to raise at your next appointment.

Frequently asked questions

Is a stool report that names a parasite worth acting on?

Accuracy is not the problem. Relevance is. A panel can correctly name organisms most healthy people carry, and a fungal report resembled the same person over time no better than it resembled a stranger’s. A consensus statement from sixty-nine specialists found no proven clinical value in the consumer versions. Read a result as a question rather than an instruction. Learning to read a claim before paying for it applies here too.

What does a low diversity score mean?

Less than the report implies. Diversity was not significantly associated with dying in a cohort of thousands, and adding the microbiome to ordinary clinical risk factors changed nothing at all. Richness also tracks stool consistency and transit speed, and it swings with the season in healthy people. Treat a low number as a prompt to look at fermentable intake and drug exposure. The fuel your colon lining runs on is the more useful question.

Does a positive candida result mean I need an antifungal?

Usually it means you eat. In controlled-diet volunteers, stool fungi traced back to the mouth or the plate, and brushing teeth more often lowered the candida signal. Genuine fungal expansion happens after bacterial loss, in immunosuppressed patients, and looks nothing like a wellness printout. Bring the result to your physician rather than to a protocol you bought. Testing well is a discipline of its own.

Can food rebuild the community without killing anything first?

That is the arm with better evidence behind it. Adding fermented food raised diversity and lowered 19 of 93 inflammatory proteins, while added fiber raised the community’s carbohydrate-degrading capacity instead. Both results were secondary to a null primary endpoint in a small trial, so read direction rather than magnitude. Neither arm required an antimicrobial. A working gut community shows up in joints, not only in digestion.

How do I restore gut flora after antibiotics?

Slowly, and by feeding rather than by buying a replacement community. Diversity stayed suppressed for months after a single course, and the butyrate producers took the worst of it. Probiotics tested against doing nothing delayed the return of a person’s own community, while banked autologous stool restored it in days. Density comes from substrate arriving most days. What a monitor can and cannot tell you follows the same rule.

Sources

1. Cotter, J. M., Thomas, J., Birkholz, M., Ambroggio, L., Holstein, J., & Dominguez, S. R. (2021). Clinical impact of a diagnostic gastrointestinal panel in children. Pediatrics, 147(5), e2020036954. https://doi.org/10.1542/peds.2020-036954
2. Porcari, S., Mullish, B. H., Asnicar, F., Ng, S. C., Zhao, L., Hansen, R., O’Toole, P. W., Raes, J., Hold, G., Putignani, L., Hvas, C. L., Zeller, G., Koren, O., Tun, H., Valles-Colomer, M., Collado, M. C., Fischer, M., Allegretti, J., Iqbal, T., … Ianiro, G. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X
3. Auchtung, T. A., Fofanova, T. Y., Stewart, C. J., Nash, A. K., Wong, M. C., Gesell, J. R., Auchtung, J. M., Ajami, N. J., & Petrosino, J. F. (2018). Investigating colonization of the healthy adult gastrointestinal tract by fungi. mSphere, 3(2), e00092-18. https://doi.org/10.1128/mSphere.00092-18
4. Gabrielli, S., Furzi, F., Fontanelli Sulekova, L., Taliani, G., & Mattiucci, S. (2020). Occurrence of Blastocystis subtypes in patients from Italy revealed association of ST3 with a healthy gut microbiota. Parasite Epidemiology and Control, 9, e00134. https://doi.org/10.1016/j.parepi.2020.e00134
5. Asnicar, F., Berry, S. E., Valdes, A. M., Nguyen, L. H., Piccinno, G., Drew, D. A., Leeming, E., Gibson, R., Le Roy, C., Khatib, H. A., Francis, L., Mazidi, M., Mompeo, O., Valles-Colomer, M., Tett, A., Beghini, F., Dubois, L., Bazzani, D., Thomas, A. M., … Segata, N. (2021). Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nature Medicine, 27(2), 321-332. https://doi.org/10.1038/s41591-020-01183-8
6. Salosensaari, A., Laitinen, V., Havulinna, A. S., Meric, G., Cheng, S., Perola, M., Valsta, L., Alfthan, G., Inouye, M., Watrous, J. D., Long, T., Salido, R. A., Sanders, K., Brennan, C., Humphrey, G. C., Sanders, J. G., Jain, M., Jousilahti, P., Salomaa, V., … Niiranen, T. (2021). Taxonomic signatures of cause-specific mortality risk in human gut microbiome. Nature Communications, 12(1), 2671. https://doi.org/10.1038/s41467-021-22962-y
7. Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R. Y., Joossens, M., & Raes, J. (2016). Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut, 65(1), 57-62. https://doi.org/10.1136/gutjnl-2015-309618
8. Smits, S. A., Leach, J., Sonnenburg, E. D., Gonzalez, C. G., Lichtman, J. S., Reid, G., Knight, R., Manjurano, A., Changalucha, J., Elias, J. E., Dominguez-Bello, M. G., & Sonnenburg, J. L. (2017). Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science, 357(6353), 802-806. https://doi.org/10.1126/science.aan4834
9. Wastyk, H. C., Fragiadakis, G. K., Perelman, D., Dahan, D., Merrill, B. D., Yu, F. B., Topf, M., Gonzalez, C. G., Van Treuren, W., Han, S., Robinson, J. L., Elias, J. E., Sonnenburg, E. D., Gardner, C. D., & Sonnenburg, J. L. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137-4153.e14. https://doi.org/10.1016/j.cell.2021.06.019
10. Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., Horn, M., Cohen, Y., Moor, A. E., Zeevi, D., Korem, T., Kotler, E., Harmelin, A., Itzkovitz, S., Maharshak, N., … Elinav, E. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT.. Cell, 174(6), 1406-1423.e16. https://doi.org/10.1016/j.cell.2018.08.047

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 18 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.